True Wealth Design’s Immunome IMNM Stock Holding History

True Wealth Design’s Portfolio IMNM Stock Details IMNM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-18	Closed	-$394	–	2768
2026 Q1	$394	Hold	18	–	–	﹤0.01%	2135
2025 Q4	$387	Hold	18	–	–	﹤0.01%	2031
2025 Q3	$211	Sell	18 -8	-31%	-$80	﹤0.01%	2290
2025 Q2	$242	Buy	26 +18	+225%	+$148	﹤0.01%	2011
2025 Q1	$54	Buy	+8	New	+$77	﹤0.01%	2363

Other funds holding IMNM

Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return

Scharf Investments Los Gatos, California $3.03B AUM 7.75% 1-Year Est. Return

MFG

Magnus Financial Group New York $1.41B AUM 23.4% 1-Year Est. Return

SFA

Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return

PSP Research Newtown Square, Pennsylvania $188M AUM

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

True Wealth Design's IMNM Position: Q2 2026 in Review

True Wealth Design sold out of Immunome (IMNM) in Q2 2026, closing a stake of 18 shares — an estimated $394 sold.

True Wealth Design first reported a position in IMNM in Q1 2025 and held it in 5 quarters. The position peaked at $394 in Q1 2026. 7 funds tracked by Wall St. Rank hold IMNM as of Q2 2026.

True Wealth Design reported no remaining Immunome position as of Q2 2026 after selling out during the quarter.
True Wealth Design sold 18 Immunome shares in Q2 2026, an estimated $394.
True Wealth Design first reported a position in Immunome in Q1 2025 and held it in 5 quarters.
True Wealth Design's Immunome position peaked at $394 in Q1 2026.
7 funds tracked by Wall St. Rank held Immunome as of Q2 2026.

Based on True Wealth Design's 13F filing for Q2 2026, filed 16 Jul 2026.